Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and TherapeuticsBusiness Wire • 01/10/22
Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare DiseasesBusiness Wire • 01/10/22
Pfizer Covid vaccine protects adolescents against multisystem inflammatory syndrome, CDC saysCNBC • 01/07/22
Pfizer Inc. (PFE) CEO Dr. Albert Bourla Presents at Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference (Transcript)Seeking Alpha • 01/06/22
Pfizer's Codex DNA Deal Hints At Lucrative Pivot To mRNA - Keep An Eye On This SpaceSeeking Alpha • 01/06/22
Pfizer upgraded to buy at BofA as Paxlovid likely to offset patent expiration concernsMarket Watch • 01/05/22
Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock PlaysBenzinga • 01/05/22
After Successful COVID-19 Vaccine, Pfizer, BioNTech Come Together For mRNA-Based Shingles VaccineBenzinga • 01/05/22
Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United StatesPRNewsWire • 01/05/22